Erin Mills Investment

Erin Mills Investment Corporation is a private Canadian investment firm that specializes in the healthcare and medical technology sectors. The firm is known for its patient capital approach, providing long-term funding and strategic guidance to innovative companies rather than following traditional venture capital cycles. Its most prominent success was its foundational investment in Baylis Medical, a developer of high-end cardiology and spine products that was acquired by Boston Scientific for $1.75 billion in 2022. Erin Mills Investment Corporation continues to support the medical device ecosystem, notably through its ongoing investment in Kardium, which develops advanced treatments for atrial fibrillation. The company operates as a family office for the Phelan family, who have a long history of business leadership in Canada.